bioneutra global corpor announc financi result tenmonth period end decemb 31 2014 edmonton albertamarketwir apr 30 2015 bioneutra global corpor bioneutra compani csebga pleas announc today audit financi result ten month period end decemb 31 2014 bioneutra function health food ingredi manufactur use patent process produc isomaltooligosaccharid imo sell trademark vitafib highlight tenmonth period end decemb 31 2014 tenmonth period end decemb 31 2014 bioneutra report revenu 13060336 72 increas revenu 7577334 twelvemonth period end februari 28 2014 compani increas revenu driven grow sale vitafib food manufactur target function health food market compani gross margin percentag tenmonth period end decemb 31 2014 45 contribut net incom 4258670 018 per share compar net incom 678856 twelvemonth period end februari 28 2014 decemb 31 2014 compani cash balanc 2084687 work capit 3976934 compar 1190600 350477 februari 28 2014 compani also access 500000 credit facil assist work capit need howev compani drawn credit facil decemb 31 2014 novemb 4 2014 bioneutra list canadian secur exchang cse symbol bga cse list conclud step transact wherebi bioneutra north america inc bioneutra intern limit becam subsidiari compani novemb 25 2014 bioneutra north america inc award bioalberta compani year award 15 thannual bioalberta agm award gala award present bioneutra north america inc signific achiev within marketplac alberta busi communiti strong perform leadership role see q4 2014 bioneutra began sell vitafib manufactur consum europ unit kingdom support european distribut establish warehous facil amsterdam subsequ eventson januari 5 2015 bioneutra north america inc list alberta ventur fast 50 program recogn alberta busi signific growth revenu asset capit expenditur employe threeyear period see march 2015 bioneutra north america inc reach agreement promin global onlin retail amazoncom sell vitafib onlin store april 23 2015 bioneutra north america inc enter agreement acquir mixedus manufactur offic build approxim 47000 squar feet situat 265 acr land light industri area edmonton alberta compani intend use properti head offic establish canadian manufactur capac expand research develop capabl compani expect complet purchas properti q3 2015 begin renov short thereaft financi summari tenmonth period end decemb 31 2014 revenueincreaseten month endeddecemb endedfebruari sale tenmonth period end decemb 31 2014 13060336 72 increas sale 7577334 twelvemonth period end februari 28 2014 increas revenu result grow sale vitafib major function health food manufactur turn experienc signific growth global sale gross profitth compani gross profit tenmonth period end decemb 31 2014 5891181 gross margin 45 repres increas 2314292 gross profit 3576889 twelvemonth period end februari 28 2014 net incomeincreaseten month endeddecemb endedfebruari sale combin steadi gross margin percentag result net incom 4258670 018 per share tenmonth period end decemb 31 2014 repres greater fivefold increas net incom 678856 twelvemonth period end februari 28 2014 financi condit liquidityat decemb 31 2014 compani cash balanc 2084687 work capit 3976934 compar 1190600 350477 februari 28 2014 compani also access 500000 credit facil assist work capit need howev compani drawn credit facil decemb 31 2014 incom tax recoverya decemb 31 2014 compani canadian tax loss tax benefit 1574015 loss may carri forward expir begin 2030 defer incom tax asset recogn amalgam compani subsidiari provid loss carryforward compani may use offset taxabl incom futur bioneutrabioneutra busi research develop product commerci ingredi nutraceut function mainstream food beverag focus oligosaccharid compani lead commerci product vitafib advanc function health food ingredi scientif made natur agricultur product vitafib natur sweet lower calori regular sugar vitafib also natur sourc dietari fiber provid low calori solubl prebiot fiber human digest health compani produc vitafib use patent process natur transform starch molecul local agricultur cereal crop includ corn wheat barley potato tapioca function health molecul isomaltooligosaccharid imo vitafib manufactur process base upon natur enzymat convers starch molecul without chemic modif involv make vitafib natur food ingredi vitafib also nongmo veganfriend glutenfre kosher halal certifi avail certifi organ compani custom includ mix small medium enterpris smes number highprofil food manufactur canada unit state europ unit kingdom mexico vitafib also avail retail purchas across globe amazoncom directtoconsum retail vitafib fda gras european food safeti author health canada approv inform bioneutra avail compani websit sedar websit cse websit informationthi press releas may includ forwardlook inform within mean canadian secur legisl concern busi bioneutra forwardlook inform base certain key expect assumpt made manag bioneutra although bioneutra believ expect assumpt forwardlook inform base reason undu relianc place forwardlook inform bioneutra give assur prove correct forwardlook statement contain press releas made date press releas bioneutra disclaim intent oblig updat public forwardlook inform whether result new inform futur event result otherwis requir applic secur law news releas constitut offer sell solicit offer buy secur describ herein unit state secur describ herein regist unit state secur act 1933 amend applic secur law state unit state may offer sold unit state account benefit person unit state absent exempt registr requir bioneutra global corporationmr bill smithchairman senior vice 4661481 ext 